Pfizer and Moderna could score $32 billion in Covid-19 vaccine sales -- in 2021 alone

April 21, 2021

New York (CNN Business)The imminent authorization of Pfizer's Covid-19 vaccine in the United States is a momentous occasion for science, the economy and humanity. The milestone is also a major moneymaker for the companies that developed the vaccines.

Wall Street analysts are projecting Pfizer and Moderna will generate $32 billion in Covid-19 vaccine revenue -- next year alone.

That doesn't take into account the goodwill boost these companies will receive by helping to end the worst pandemic in a century. That boost is magnified for Moderna (MRNA), a young biotech company that few people had heard of before 2020 that could now be on the cusp of getting its own FDA authorization.

Pfizer (PFE) by itself is projected to haul in $19 billion in Covid-19 vaccine revenue in 2021, according to Morgan Stanley. That's on top of an estimated $975 million in 2020 vaccine revenue.

Pfizer will split its revenues with BioNTech(BNTX), the German company it partnered with to develop the vaccine. A panel of FDA advisers recommended Thursday that the agency grant emergency use authorization to the vaccine candidate the pair developed. US officials have said they are working "rapidly" to give the vaccine the green light.

more news here: https://www.cnn.com/2020/12/11/business/pfizer-vaccine-covid-moderna-revenue/index.html